RGC:NASDAQRegencell Bioscience Holdings Limited Analysis
Data as of 2026-05-20 - not real-time
$27.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Regencell Bioscience (RGC) is trading in a technically bullish window, with price sitting above its short‑term moving averages but still below the long‑term average, and the 14‑day RSI hovering near the mid‑range. However, the MACD has turned bearish and the stock exhibits an exceptionally high beta and 30‑day volatility, signaling sharp price swings. Fundamentally, the company shows no revenue, negative cash flow, and an astronomically high price‑to‑book multiple, indicating severe overvaluation.
Compounding the financial weakness are multiple securities‑fraud class‑action notices, creating significant legal and reputational risk that could further pressure the share price.
Compounding the financial weakness are multiple securities‑fraud class‑action notices, creating significant legal and reputational risk that could further pressure the share price.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish MACD divergence despite short‑term bullish price action
- Extremely high beta and volatility increasing downside risk
- Ongoing securities‑fraud litigation creating legal uncertainty
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Fundamental deficits: zero revenue, negative cash flow, and massive price‑to‑book ratio
- Potential for further share price erosion from class‑action outcomes
- Lack of earnings visibility and uncertain product commercialization timeline
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Possible upside if the company successfully brings a TCM‑based therapy to market
- Current valuation suggests limited upside without a dramatic business turnaround
- High structural risks remain, so a cautious stance is warranted
Key Metrics & Analysis
Financial Health
ROE-54.81%
ROA-33.20%
Debt/Equity11.20
P/B Ratio2700.0
Op. Cash Flow$-3113576
Free Cash Flow$-1507277
Industry P/E27.2
Technical Analysis
TrendBullish
RSI46.6
Support$25.50
Resistance$32.00
MA 20$28.24
MA 50$27.55
MA 200$21.59
MACDBearish
VolumeIncreasing
Fear & Greed Index89.3
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta3.31
Volatility78.65%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.